Study of ESG401 in Adults With Solid Tumors

Clinical trial NCT04892342 · COMPLETED

Trial details

NCT number: NCT04892342
Sponsor: Shanghai Escugen Biotechnology Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast Neoplasms, Lung Neoplasms,Colorectal Neoplasms, Bladder Neoplasm of Stomach Neoplasms,Ovarian

Start date: 2021-09-14
Primary completion: 2025-06-30
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.